He, Zuowen
Wang, Dao Wen
Funding for this research was provided by:
National Natural Science Foundation of China (81790624, 81900341)
Tongji Hospital (HUST) Foundation for Excellent Young Scientist
Article History
Received: 19 June 2022
Revised: 3 July 2022
Accepted: 6 July 2022
First Online: 21 July 2022
Competing interests
: The authors declare no competing interests. Dao Wen Wang is the editorial board member of <i>Signal Transduction and Targeted Therapy</i>, but he has not been involved in the process of the manuscript handling.